News

Filter

Current filters:

SandozAsia-Pacific

1 to 9 of 10 results

Sandoz to commercialize Taiwan Liposome’s antifungal

Sandoz to commercialize Taiwan Liposome’s antifungal

19-12-2013

Taipei-based biopharmaceutical company Taiwan Liposome Company has entered into a collaboration agreement…

Amphotericin BAntibiotics and Infectious diseasesAsia-PacificGenericsLicensingNovartisSandozTaiwan Liposome

Proposal for a sole supply arrangement for fentanyl patches in New Zealand

08-07-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to list a…

Asia-PacificfentanylFentanyl SandozNeurologicalNovartisPharmaceuticalPricingRegulationSandoz

Sandoz expands strategic alliance with Nipro in Japan; Shionogi licenses drug to Ildong

14-07-2011

Sandoz, a generics subsidiary of US drug major Novartis (NOVN: VX) has entered into a strategic alliance…

Asia-PacificGenericsIldong PharmaLicensingNovartisPharmaceuticalpirfenidoneSandozShionogi

US court rejects Astellas’ appeal on generic immunosuppressants

14-09-2009

The US District Court in Washington DC has denied the Temporary Restraining Order and Preliminary Injunction…

Asia-PacificGenericsImmunologicalsNorth AmericaNovartisNystatinOralPrografProtopicSandoztacrolimus

Indian pharmaceutical market outlook to 2014: trends, key players and forecasts

26-08-2009

India's per capita health care expenditure is well below international recommendations and compares poorly…

Asia-PacificNovartisPharmaceuticalSandoz

1 to 9 of 10 results

Back to top